Opioid Use Disorder (OUD) is a type of chronic disorder that is associated with repeated self-administration of opioids, prolonged self-administration of opioid drugs and compulsive use of opioid drugs. Patients addicted to medical opioids, and the patients addicted to non-medical opioids, both suffers through the opioid use disorder. Opioid use disorder causes due to genetic and environmental factors.
MARKET DYNAMICS
The Opioid Use Disorder market is anticipated to grow in the forecast period owing to driving factors such as rising incidence of opioid use disorder, government policies to control the opioid use disorder, and rising investments by private pharmaceutical players.
MARKET SCOPE
The "Global Opioid Use Disorder Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Opioid Use Disorder market with detailed market segmentation by drug type, and geography. The global Opioid Use Disorder market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Opioid Use Disorder market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Global Opioid Use Disorder market is segmented on the basis of drug type. Based on drug type the market is segmented into Buprenorphine, Methadone, and Naltrexone. Buprenorphine segment is further sub segmented into Bunavail, Sublocade, Suboxone, Zubsolv, and Others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Opioid Use Disorder market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Opioid Use Disorder market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Opioid Use Disorder market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Opioid Use Disorder market in these regions.
MARKET PLAYERS
The reports cover key developments in the Opioid Use Disorder market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Opioid Use Disorder market are anticipated to lucrative growth opportunities in the future with the rising demand for Opioid Use Disorder market in the global market. Below mentioned is the list of few companies engaged in the Opioid Use Disorder market.
The report also includes the profiles of key Opioid Use Disorder market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Indivior
- Alkermes
- Titan Pharmaceuticals
- Hikma Pharmaceuticals
- Teva Pharmaceuticals
- MediciNova
- Orexo
- Camurus
- Omeros
- Amygalda Neurosciences